Navigation Links
Stereotaxis to Present at the Stifel Nicolaus Healthcare Conference on September 7, 2011
Date:8/25/2011

terventional labs, enhancing the physician workflow through a consolidated display of multiple systems and eliminating the challenge of interacting simultaneously with many separate diagnostic systems. Odyssey™ Enterprise Cinema then captures a complete record of synchronized procedure data that can be viewed live or from a comprehensive archive of cases performed.  Odyssey™ then enables hospitals to efficiently share live and recorded clinical data anywhere around the world to maximize referrals and promote collaboration.

The core components of the Stereotaxis systems have received regulatory clearance in the U.S., Europe, Canada and elsewhere. For more information, please visit www.stereotaxis.com and www.odysseyexperience.com.

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products in the marketplace, the effect of global economic conditions on the ability and willingness of customers to purchase our systems and the timing of such purchases, competitive factors, changes resulting from the recently enacted healthcare reform in the U.S., including changes in government reimbursement procedures, dependence upon third-party vendors, timing of regulatory approvals, and other risks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of t
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Stereotaxis to Present at the Canaccord Genuity Growth Conference on August 11, 2011
2. Stereotaxis Reports Second Quarter Financial Results; Rebalances Investment Around Commercialization of Epoch™ and Odyssey™
3. Stereotaxis to Report Second Quarter 2011 Financial Results and Conduct Conference Call on August 8, 2011
4. Stereotaxis and Biosense Webster Announce New Strategic Collaboration
5. Stereotaxis Continued Leadership in Scientific Outcome Data Prominently Displayed with Multiple Key Presentations at HRS 2011
6. Stereotaxis Reports First Quarter 2011 Financial Results
7. Stereotaxis Introduces New Electrophysiology Platform: Epoch™
8. Stereotaxis to Present at Upcoming Investor Conferences
9. Stereotaxis Reports 2010 Financial Results, Provides 2011 Financial Outlook
10. Stereotaxis Announces First Worldwide Use of Remote Magnetic Navigation for Renal Ablation to Treat Hypertension
11. Stereotaxis to Report Fourth Quarter and Full Year 2010 Financial Results and Conduct Conference Call on February 28, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 2014 About 8 million Americans have peripheral ... of fatty plaque in the arteries, according to recent ... and in incidences of diabetes and obesity, the ... Extremity Arterial RevascularizatioN (LEARN) meeting, Oct. 9–11 in ... interested residents and fellows will be able to gain ...
(Date:8/27/2014)... LAKE CITY , Aug. 27, 2014 Varian ... will expand its current Salt Lake City ... currently underway outside of Utah to ... over the next 20 years. " ... engineering and technical talent, many of whom can be credited ...
(Date:8/27/2014)... 2014 Decision Resources Group finds that the ... Memphis health system and hospital sector in ... rivals Methodist Le Bonheur Healthcare and Baptist Memorial Health ... patient care. In addition, a national contract recently signed ... plan enrollment in the Memphis ...
Breaking Medicine Technology:LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 4Memphis-area Health Systems Turn Attention to Clinical Integration 2
... Reportlinker.com announces that a new market ... The Outlook for Pharmaceuticals ... http://www.reportlinker.com/p0203105/The-Outlook-for-Pharmaceuticals-in-Northern-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory The Northern European ... pharmaceutical market value of over US$26 billion ...
... Diagnostics Incorporated (NYSE: DGX ), the world,s ... that it is scheduled to speak at the Lazard ... City.  The presentation is scheduled for Tuesday, November 15, ... the conference, the company will reaffirm its 2011 outlook ...
Cached Medicine Technology:The Outlook for Pharmaceuticals in Northern Europe 2The Outlook for Pharmaceuticals in Northern Europe 3The Outlook for Pharmaceuticals in Northern Europe 4Quest Diagnostics to Speak at the Lazard Capital Markets 8th Annual Healthcare Conference 2Quest Diagnostics to Speak at the Lazard Capital Markets 8th Annual Healthcare Conference 3Quest Diagnostics to Speak at the Lazard Capital Markets 8th Annual Healthcare Conference 4
(Date:8/27/2014)... 27, 2014 When Jagger was 20 years ... his mother; one that he credits as one of the ... had news that she could set him up with a ... disabilities. Jagger took that job, and he has now spent ... past two decades, he also worked in school boards, employment ...
(Date:8/27/2014)... (HealthDay News) -- A new study finds that continuous ... seniors with sleep apnea. CPAP is widely used ... condition in which the airway relaxes and narrows during ... to daytime drowsiness. CPAP keeps the ... a patient,s nose via a mask that is worn ...
(Date:8/27/2014)... many aspects of our lives. But in addition to ... during development, but can be altered by our lifestyle ... parents and grandparents. , The epigenome consists of chemical ... whether genes are expressed or silenced. , This means ... also that it may be possible to diagnose and ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Tejal K. Gandhi, ... Foundation (NPSF) and the NPSF Lucian Leape Institute, is ... the August 25 issue of Modern Healthcare magazine. Also on ... and Andrew Sussman, MD, MBA; NPSF Lucian Leape Institute ... MD, who is a member of both the Institute and ...
(Date:8/27/2014)... Scientists at The Scripps Research Institute (TSRI) have ... can be associated with alcohol dependence. , This ... type 1 (Nf1), which TSRI scientists found is linked ... Nf1 regulates gamma-aminobutyric acid (GABA), a neurotransmitter that lowers ... novel and seminal study provides insights into the cellular ...
Breaking Medicine News(10 mins):Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4Health News:Sleep Apnea Treatment Helps Seniors, Study Finds 2Health News:Scientists map the 'editing marks' on fly, worm, human genomes 2Health News:Scientists map the 'editing marks' on fly, worm, human genomes 3Health News:Scientists map the 'editing marks' on fly, worm, human genomes 4Health News:NPSF President Among 100 Most Influential in Health Care 2Health News:NPSF President Among 100 Most Influential in Health Care 3Health News:Scripps Research Institute scientists link alcohol-dependence gene to neurotransmitter 2
... adolescence and teenage has always remained a problem for parents ... experiment and susceptibility to get easily influenced by peers ... that teenagers who enjoy popularity are more likely to smoke ... among popular students in 16 Southern California middle schools. Over ...
... of people suffering from diabetes is already over 194 ... by 333 million by 2025. Type II diabetes is ... characterized by a relative disparity between endogenous insulin production ... contrast to Type I diabetes, there is always some ...
... It is now official through the scientific circles that soft ... the risk of heart disease. ,The study is one ... researchers found that reduced risk for coronary heart disease (CHD) ... fats (e.g., soft, trans fat-free margarines made from soybean and ...
... cases has reached about 1.2 million worldwide and Statistics show ... urban India and has overtaken cancer of the cervix as ... according to a study conducted on women and cancer in ... motherhood are some factors that can lead to a high ...
... shares fell by 1.3% to close at $43.80 following U.S. ... Xinlay. Increased number of scientists and analysts question the efficiency ... drug. ,The drug that is to be used ... III trial leading to disapproval of the drug by the ...
... be used to treat childhood cholera. ,Researchers in ... be treated effectively with a single dose // of ... online by The Lancet., ,Cholera is a major ... less-developed countries. In the resource-limited countries where cholera occurs, ...
Cached Medicine News:Health News:Popularity Among Peers Increases Susceptibility To Smoking Habit Among School Children 2Health News:Sitagliptin, Under Investigation For Type 2 Diabetes 2Health News:PUFA Good For Heart: Gets The Scientific Seal 2Health News:Abbott’s Laboratories R&D Capabilities Questione 2
... for the quantitative determination of ... or plasma. Two vials, dry ... must be purchased separately for ... reaction. Wavelength: 340 nm. Linearity: ...
Intended for the quantitative determination of total protein in serum. Reaction: endpoint. Wavelength: 540 nm. Linearity: 12 g/dL (120 g/L). Ready to use liquid reagent....
... Intended for the quantitative determination ... Reaction: kinetic, lag phase of ... by linear phase of at ... nm. Linearity: 100 mg/dL (35.6 ...
For the quantitative determination of direct bilirubin in human serum. Linearity: 20 mg/dl...
Medicine Products: